Transgenic neuronal expression of a cyclin-dependent kinase inhibitor protects neurons from cell death in vivo

被引：0
|
作者：
Ueberham, U. [1 ]
Lindner, R. [1 ]
Ueberham, E. [1 ]
Berger, S. [2 ]
Frahm, C. [3 ]
Brueckner, M. K. [1 ]
Frick, E. [1 ]
Bartsch, D. [2 ]
Gruschka, H. [1 ]
Arendt, T. [1 ]
机构：
[1] Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany
[2] Univ Heidelberg, Dept Mol Biol, Cent Inst Mental Hlth, D-6800 Mannheim, Germany
[3] Univ Jena, Dept Neurol, Jena, Germany
来源：
JOURNAL OF NEUROCHEMISTRY | 2009年 / 110卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
37
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [31] Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo
    Neystat, M
    Rzhetskaya, M
    Oo, TF
    Kholodilov, N
    Yarygina, O
    Wilson, A
    El-Khodor, BF
    Burke, RE
    JOURNAL OF NEUROCHEMISTRY, 2001, 77 (06) : 1611 - 1625
  • [32] Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation
    Cicero, S
    Herrup, K
    JOURNAL OF NEUROSCIENCE, 2005, 25 (42): : 9658 - 9668
  • [33] Expression of cyclin-dependent kinase inhibitor p21 in human liver
    Crary, GS
    Albrecht, JH
    HEPATOLOGY, 1998, 28 (03) : 738 - 743
  • [34] Expression of the cyclin-dependent kinase inhibitor p27(kip) in keratoacanthoma
    Hu, W
    Cook, T
    Oh, C
    Penneys, N
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 583 - 583
  • [35] Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
    Bose, Prithviraj
    Simmons, Gary L.
    Grant, Steven
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (06) : 723 - 738
  • [36] EXPRESSION OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P16 DURING THE ONGOING CELL-CYCLE
    SOUCEK, T
    PUSCH, O
    HENGSTSCHLAGEROTTNAD, E
    WAWRA, E
    BERNASCHEK, G
    HENGSTSCHLAGER, M
    FEBS LETTERS, 1995, 373 (02) : 164 - 169
  • [37] Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4
    Soni, R
    O'Reilly, T
    Furet, P
    Muller, L
    Stephan, C
    Zumstein-Mecker, S
    Fretz, H
    Fabbro, D
    Chaudhuri, B
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (06): : 436 - +
  • [38] THE P21 CYCLIN-DEPENDENT KINASE INHIBITOR SUPPRESSES TUMORIGENICITY IN-VIVO
    YANG, ZY
    PERKINS, ND
    OHNO, T
    NABEL, EG
    NABEL, GJ
    NATURE MEDICINE, 1995, 1 (10) : 1052 - 1056
  • [39] Complexities in the development of cyclin-dependent kinase inhibitor drugs
    Sausville, EA
    TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) : S32 - S37
  • [40] Cyclin-Dependent Kinase Inhibitor-Associated Thromboembolism
    Olson, Sven R.
    DeLoughery, Thomas G.
    Shatzel, Joseph J.
    JAMA ONCOLOGY, 2019, 5 (02) : 141 - 142
12345